ES2141957T3 - Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales. - Google Patents

Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.

Info

Publication number
ES2141957T3
ES2141957T3 ES95930863T ES95930863T ES2141957T3 ES 2141957 T3 ES2141957 T3 ES 2141957T3 ES 95930863 T ES95930863 T ES 95930863T ES 95930863 T ES95930863 T ES 95930863T ES 2141957 T3 ES2141957 T3 ES 2141957T3
Authority
ES
Spain
Prior art keywords
raloxifene
analogs
treatment
production
viral diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95930863T
Other languages
English (en)
Inventor
Andrew Lawrence Glasebrook
David Lynn Phillips
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2141957T3 publication Critical patent/ES2141957T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

METODO PARA INHIBIR LA REPLICACION VIRAL QUE SUPONE LA ADMINISTRACION A UN SER HUMANO QUE LO NECESITE UNA CANTIDAD EFECTIVA DE UN COMPUESTO QUE TENGA LA FORMULA (I), DONDE R{SUP,1} Y R{SUP,3} SON INDEPENDIENTEMENTE HIDROGENO, -CH{SUB,3}, (A), O (B), EN DONDE AR ES OPCIONALMENTE SUSTITUTIVO DE FENIL; R{SUP,2} SE SELECCIONA A PARTIR DEL GRUPO INTEGRADO POR PIRROLIDINA, HEXAMETILENEIMINO, Y PIPERIDINO; O UN COMPUESTO SALINO ACEPTABLE FARMACEUATICAMENTE O UN SOLVATO DE LO ANTERIOR.
ES95930863T 1994-08-22 1995-08-21 Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales. Expired - Lifetime ES2141957T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/294,171 US5494920A (en) 1994-08-22 1994-08-22 Methods of inhibiting viral replication

Publications (1)

Publication Number Publication Date
ES2141957T3 true ES2141957T3 (es) 2000-04-01

Family

ID=23132219

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95930863T Expired - Lifetime ES2141957T3 (es) 1994-08-22 1995-08-21 Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.

Country Status (15)

Country Link
US (1) US5494920A (es)
EP (1) EP0771200B1 (es)
JP (1) JPH10504572A (es)
AT (1) ATE189601T1 (es)
AU (1) AU3408795A (es)
CA (1) CA2198122A1 (es)
DE (1) DE69515038T2 (es)
DK (1) DK0771200T3 (es)
ES (1) ES2141957T3 (es)
GR (1) GR3033269T3 (es)
IL (1) IL115014A0 (es)
MX (1) MX9701329A (es)
PT (1) PT771200E (es)
WO (1) WO1996005830A1 (es)
ZA (1) ZA956986B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3798024B2 (ja) 1995-12-13 2006-07-19 メルク エンド カンパニー インコーポレーテッド 成長ホルモン分泌促進物質レセプターアッセイ
US6531314B1 (en) 1996-12-10 2003-03-11 Merck & Co., Inc. Growth hormone secretagogue receptor family
US6458811B1 (en) 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
CZ300341B6 (cs) 1996-03-26 2009-04-22 Eli Lilly And Company Farmaceutická kompozice obsahující raloxifen
HUP0200871A3 (en) 1999-05-04 2004-04-28 Strakan Int Ltd Androgen glycosides and androgenic activity thereof
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
US20100021455A1 (en) * 2004-12-08 2010-01-28 Cedars-Sinai Medical Center Methods for diagnosis and treatment of crohn's disease
WO2008109782A2 (en) * 2007-03-06 2008-09-12 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease in children
WO2008101133A2 (en) * 2007-02-14 2008-08-21 Cedars-Sinai Medical Center Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease
WO2008106451A2 (en) * 2007-02-26 2008-09-04 Cedars-Sinai Medical Center Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease
WO2008116150A2 (en) 2007-03-21 2008-09-25 Cedars-Sinai Medical Center Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease
WO2008134569A2 (en) * 2007-04-26 2008-11-06 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease in the puerto rican population
US20100099640A1 (en) * 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
US20100144903A1 (en) * 2007-05-04 2010-06-10 Cedars-Sinai Medical Center Methods of diagnosis and treatment of crohn's disease
US20110177969A1 (en) * 2008-10-01 2011-07-21 Cedars-Sinai Medical Center The role of il17rd and the il23-1l17 pathway in crohn's disease
US20110189685A1 (en) * 2008-10-22 2011-08-04 Cedars-Sinai Medical Center Methods of using jak3 genetic variants to diagnose and predict crohn's disease
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
US9580752B2 (en) 2008-12-24 2017-02-28 Cedars-Sinai Medical Center Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy
WO2013190520A2 (en) 2012-06-22 2013-12-27 The General Hospital Corporation Gh-releasing agents in the treatment of vascular stenosis and associated conditions
CA2908553A1 (en) 2013-03-27 2014-10-02 Cedars-Sinai Medical Center Mitigation and reversal of fibrosis and inflammation by inhibition of tl1a function and related signaling pathways
WO2015010108A1 (en) 2013-07-19 2015-01-22 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
US10328082B2 (en) 2014-05-30 2019-06-25 Pfizer Inc. Methods of use and combinations
KR20180127416A (ko) 2016-03-17 2018-11-28 세다르스-신나이 메디칼 센터 Rnaset2를 통한 염증성 장 질환의 진단 방법
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体

Also Published As

Publication number Publication date
PT771200E (pt) 2000-07-31
EP0771200A1 (en) 1997-05-07
WO1996005830A1 (en) 1996-02-29
MX9701329A (es) 1997-05-31
JPH10504572A (ja) 1998-05-06
EP0771200B1 (en) 2000-02-09
CA2198122A1 (en) 1996-02-29
AU3408795A (en) 1996-03-14
ZA956986B (en) 1997-02-21
DE69515038T2 (de) 2000-06-29
US5494920A (en) 1996-02-27
GR3033269T3 (en) 2000-09-29
ATE189601T1 (de) 2000-02-15
IL115014A0 (en) 1995-12-08
DK0771200T3 (da) 2000-05-15
DE69515038D1 (de) 2000-03-16
EP0771200A4 (en) 1997-09-10

Similar Documents

Publication Publication Date Title
ES2141957T3 (es) Uso de raloxifeno y sus analogos para la produccion de un medicamento para el tratamiento de enfermedades virales.
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
ES2161238T3 (es) Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para inhibir la angiogenesis y enfermedades angiogenicas.
ES2154669T3 (es) Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para la inhibicion de la degradacion del cartilago.
ES2157960T3 (es) Procedimiento para aumentar la libido en mujeres postmenopausicas.
DK0583271T3 (da) Arylmorpholin, fremstilling og anvendelse
DK0769945T3 (da) Brug af 2-phenyl-3-aroylbenzothiophenderivater til fremstilling af et medikament til behandling af knogler og knoglebrud
ES2155895T3 (es) Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para inhibir la hiperplasia endometrial primaria.
NO970784L (no) Fremgangsmåte for opprettholdelse av tenner og oralt ben
DK0772438T3 (da) Anvendelse af benzothiophener til fremstilling af et medikament til reduktion af ardannelse under sårheling
MX9709536A (es) Metodo para reducir el factor de transcripcion bef-1.
MX9705940A (es) Metodos y composiciones para inhibir los efectos de la interleucina 6.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 771200

Country of ref document: ES